In this model, EGFR or anaplastic lymphoma kinase (ALK) gene alterations, Karnofsky performance status (KPS) score, and the presence or absence of extracranial metastases are independent risk factors for the prognosis of LMs of lung cancer. This evidence concerns the gene EGFR and lung cancer.